Education
About Us
Working with TipRanks
Follow Us
Andrew C. Jackson Insider Profile
4 Followers
Andrew C. Jackson, Corporate Controller, Principal Accounting Officer at Eiger Biopharmaceuticals, holds 2.50K shares in Calidi Biotherapeutics (Ticker: CLDI), holds 21.68K shares in Catheter Precision (Ticker: VTAK), holds 1.59K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ). Most recently, Andrew C. Jackson Bought ― shares of Calidi Biotherapeutics on Aug 25, 2025 for an estimated value of $5.00K.
Andrew C. Jackson Eiger Biopharmaceuticals (EIGRQ)Corporate Controller, Principal Accounting Officer
Eiger Biopharmaceuticals (EIGRQ)
Corporate Controller, Principal Accounting Officer
Ranked #27,453 out of 103,225 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+13.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew C. Jackson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 24, 2021 - Nov 24, 2022
Return:+98.00%
The most profitable trade made by Andrew C. Jackson
Andrew C. Jackson's Trading History
Eiger Biopharmaceuticals
Mar 17, 2015
―
Uninformative Buy
―
$13.49K
Catheter Precision
May 24, 2022
CFO
Uninformative Sell
408.30
$55.93K
Eterna Therapeutics
―
Chief Financial Officer
―
―
Calidi Biotherapeutics
Aug 25, 2025
CFO
Informative Buy
5.00K
$4.28K
List of latest transactions for each holding click on a transaction to see Andrew C. Jackson's performance on stock
You May Also Like
Andrew C. Jackson insider profile FAQ
What is the percentage of profitable transactions made by Andrew C. Jackson?
The percentage of profitable transactions made by Andrew C. Jackson is 50%.
What is the average return per transaction made by Andrew C. Jackson?
The average return per transaction made by Andrew C. Jackson is 13.20%.
What stocks does Andrew C. Jackson hold?
Andrew C. Jackson holds: EIGRQ, VTAK, ERNA, CLDI stocks.
What was Andrew C. Jackson’s latest transaction?
Andrew C. Jackson latest transaction was an Informative Buy of $5.00K.
What was Andrew C. Jackson's most profitable transaction?
Andrew C. Jackson’s most profitable transaction was an Informative Sell of VTAK stock on November 24, 2021. The return on the trade was 98.00%.
What is Andrew C. Jackson's role in Eiger Biopharmaceuticals?
Andrew C. Jackson's role in Eiger Biopharmaceuticals is Corporate Controller, Principal Accounting Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.